Common osteoporosis medication boosts immune response in lungs
Isolation and innovation: two years of the COVID-19 pandemic
6 January 2022Cost effectiveness of financial incentives for smoking cessation
6 January 2022Common osteoporosis medication boosts immune response in lungs
Researchers at the Garvan Institute of Medical Research have revealed that a common osteoporosis treatment boosts immune cells in the lung that form one of the first lines of defense against pathogens.
